Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.

Dharajiya NG, Grosu DS, Farkas DH, McCullough RM, Almasri E, Sun Y, Kim SK, Jensen TJ, Saldivar JS, Topol EJ, van den Boom D, Ehrich M.

Clin Chem. 2018 Feb;64(2):329-335. doi: 10.1373/clinchem.2017.277517. Epub 2017 Oct 5.

PMID:
28982650
2.

Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.

Bianchi DW, Chudova D, Sehnert AJ, Bhatt S, Murray K, Prosen TL, Garber JE, Wilkins-Haug L, Vora NL, Warsof S, Goldberg J, Ziainia T, Halks-Miller M.

JAMA. 2015 Jul 14;314(2):162-9. doi: 10.1001/jama.2015.7120.

PMID:
26168314
3.

The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.

Cai YH, Yao GY, Chen LJ, Gan HY, Ye CS, Yang XX.

DNA Cell Biol. 2018 Jul;37(7):626-633. doi: 10.1089/dna.2017.4112. Epub 2018 Jun 29.

PMID:
29957029
4.

Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.

Cohen PA, Flowers N, Tong S, Hannan N, Pertile MD, Hui L.

BMC Med. 2016 Aug 24;14(1):126. doi: 10.1186/s12916-016-0667-6.

5.

Using Targeted Sequencing of Paralogous Sequences for Noninvasive Detection of Selected Fetal Aneuploidies.

Ellison CK, Sun Y, Hogg G, Fox J, Tao H, McCarthy E, Sagoe B, Azab MA, Mazloom AR, Tynan J, Burcham T, Kim SK, van den Boom D, Ehrich M, Jensen TJ.

Clin Chem. 2016 Dec;62(12):1621-1629. Epub 2016 Sep 30.

6.

Noninvasive prenatal testing: the future is now.

Norwitz ER, Levy B.

Rev Obstet Gynecol. 2013;6(2):48-62. Review.

7.

Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.

Yin AH, Peng CF, Zhao X, Caughey BA, Yang JX, Liu J, Huang WW, Liu C, Luo DH, Liu HL, Chen YY, Wu J, Hou R, Zhang M, Ai M, Zheng L, Xue RQ, Mai MQ, Guo FF, Qi YM, Wang DM, Krawczyk M, Zhang D, Wang YN, Huang QF, Karin M, Zhang K.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14670-5. doi: 10.1073/pnas.1518151112. Epub 2015 Nov 9.

8.

Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.

Lebo RV, Novak RW, Wolfe K, Michelson M, Robinson H, Mancuso MS.

J Transl Med. 2015 Aug 11;13:260. doi: 10.1186/s12967-015-0569-y.

9.

Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.

Tamminga S, van Maarle M, Henneman L, Oudejans CB, Cornel MC, Sistermans EA.

Adv Clin Chem. 2016;74:63-102. doi: 10.1016/bs.acc.2015.12.004. Epub 2016 Jan 21. Review.

PMID:
27117661
10.

Maternal X chromosome copy number variations are associated with discordant fetal sex chromosome aneuploidies detected by noninvasive prenatal testing.

Wang S, Huang S, Ma L, Liang L, Zhang J, Zhang J, Cram DS.

Clin Chim Acta. 2015 Apr 15;444:113-6. doi: 10.1016/j.cca.2015.02.014. Epub 2015 Feb 14.

PMID:
25689220
11.

[Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].

Hernández-Gómez M, Ramirez-Arroyo E, Meléndez-Hernández R, Garduño-Zaraza LM, Mayén-Molina DG.

Ginecol Obstet Mex. 2015 May;83(5):277-88. Review. Spanish.

PMID:
26233973
12.

Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.

Amant F, Verheecke M, Wlodarska I, Dehaspe L, Brady P, Brison N, Van Den Bogaert K, Dierickx D, Vandecaveye V, Tousseyn T, Moerman P, Vanderstichele A, Vergote I, Neven P, Berteloot P, Putseys K, Danneels L, Vandenberghe P, Legius E, Vermeesch JR.

JAMA Oncol. 2015 Sep;1(6):814-9. doi: 10.1001/jamaoncol.2015.1883.

PMID:
26355862
13.

Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.

Li R, Wan J, Zhang Y, Fu F, Ou Y, Jing X, Li J, Li D, Liao C.

Ultrasound Obstet Gynecol. 2016 Jan;47(1):53-7. doi: 10.1002/uog.14911.

14.

Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.

Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, Zhang H, Wang W, Jong LF, Yuen OK, Chan HY, Chan WS, Choy KW.

Ultrasound Obstet Gynecol. 2014 Mar;43(3):254-64. doi: 10.1002/uog.13277. Epub 2014 Feb 10. Review.

15.

Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.

Gerundino F, Giachini C, Contini E, Benelli M, Marseglia G, Giuliani C, Marin F, Nannetti G, Lisi E, Sbernini F, Periti E, Cordisco A, Colosi E, D'ambrosio V, Mazzi M, Rossi M, Staderini L, Minuti B, Pelo E, Cicatiello R, Maruotti GM, Sglavo G, Conti A, Frusconi S, Pescucci C, Torricelli F.

J Matern Fetal Neonatal Med. 2017 Mar;30(6):710-716. doi: 10.1080/14767058.2016.1183633. Epub 2016 May 26.

PMID:
27226231
16.

Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population.

Song K, Musci TJ, Caughey AB.

J Matern Fetal Neonatal Med. 2013 Aug;26(12):1180-5. doi: 10.3109/14767058.2013.770464. Epub 2013 Mar 6.

17.

Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities.

Norton ME, Baer RJ, Wapner RJ, Kuppermann M, Jelliffe-Pawlowski LL, Currier RJ.

Am J Obstet Gynecol. 2016 Jun;214(6):727.e1-6. doi: 10.1016/j.ajog.2015.12.018. Epub 2015 Dec 18.

PMID:
26709085
18.

Noninvasive prenatal testing.

Lo JO, Cori D F, Norton ME, Caughey AB.

Obstet Gynecol Surv. 2014 Feb;69(2):89-99. doi: 10.1097/OGX.0000000000000029.

PMID:
25112487
19.

Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.

Buysse K, Beulen L, Gomes I, Gilissen C, Keesmaat C, Janssen IM, Derks-Willemen JJ, de Ligt J, Feenstra I, Bekker MN, van Vugt JM, Geurts van Kessel A, Vissers LE, Faas BH.

Clin Biochem. 2013 Dec;46(18):1783-6. doi: 10.1016/j.clinbiochem.2013.07.020. Epub 2013 Aug 8.

PMID:
23933476
20.

An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population.

Benn P, Curnow KJ, Chapman S, Michalopoulos SN, Hornberger J, Rabinowitz M.

PLoS One. 2015 Jul 9;10(7):e0132313. doi: 10.1371/journal.pone.0132313. eCollection 2015.

Supplemental Content

Support Center